Silence Therapeutics plc (SLN)

Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.74	121.33	68.79	66.05	99.57	37.48
Short-Term Investments	72.42	26	-	19.67	-	13.65
Cash & Short-Term Investments	114.16	147.33	68.79	85.72	99.57	51.13
Cash Growth	-39.62%	114.18%	-19.75%	-13.91%	94.75%	15.18%
Accounts Receivable	0.09	0.97	0.29	1.1	0.45	40.01
Other Receivables	19.96	25.94	23.69	19.79	11.04	5.75
Receivables	20.04	26.91	23.98	20.9	11.49	45.76
Prepaid Expenses	-	13.12	10.39	9.88	5.83	5.38
Other Current Assets	14.36	-	-	-	-	2.04
Total Current Assets	148.55	187.37	103.15	116.5	116.9	104.31
Property, Plant & Equipment	1.83	1.98	2.31	2.65	2.63	1.54
Long-Term Investments	-	-	-	0.34	0.41	0.41
Goodwill	10.62	9.39	9.98	9.65	10.28	11.09
Other Intangible Assets	0.32	0.31	0.36	0.39	0.03	0.02
Other Long-Term Assets	3.91	3.59	3.65	-	-	-
Total Assets	165.23	202.64	119.45	129.53	130.25	117.38
Accounts Payable	14.31	3.7	3.35	3.84	5.5	3.12
Accrued Expenses	-	12.05	11.72	10.67	8.85	8.06
Current Portion of Leases	-	0.12	0.23	0.54	0.19	0.47
Current Income Taxes Payable	-	0.65	0.47	0.71	0.25	-
Current Unearned Revenue	0.46	0.31	6.57	10.68	5.75	23.27
Total Current Liabilities	14.77	16.82	22.34	26.44	20.54	34.92
Long-Term Leases	-	-	0.12	-	-	-
Long-Term Unearned Revenue	56.31	51.79	75	76.49	98.17	70.09
Total Liabilities	71.08	68.61	97.46	102.93	118.71	105.01
Common Stock	10.29	10.29	8.85	6.49	6.08	5.69
Additional Paid-In Capital	615.11	609.56	455.77	273.11	249.6	209.89
Retained Earnings	-531.25	-485.83	-442.62	-317.2	-301.91	-251.51
Comprehensive Income & Other	-	-	-	64.19	57.78	48.3
Shareholders' Equity	94.16	134.02	21.99	26.59	11.54	12.37
Total Liabilities & Equity	165.23	202.64	119.45	129.53	130.25	117.38
Total Debt	-	0.12	0.35	0.54	0.19	0.47
Net Cash (Debt)	114.16	147.22	68.44	85.18	99.39	50.66
Net Cash Growth	-39.54%	115.09%	-19.65%	-14.29%	96.17%	15.12%
Net Cash Per Share	2.42	3.18	1.85	2.65	3.35	1.86
Filing Date Shares Outstanding	47.23	47.22	46.5	35.95	29.93	27.77
Total Common Shares Outstanding	47.23	47.22	39.62	35.94	29.93	27.77
Working Capital	133.79	170.54	80.82	90.06	96.36	69.39
Book Value Per Share	1.99	2.84	0.56	0.74	0.39	0.45
Tangible Book Value	83.22	124.32	11.65	16.56	1.23	1.25
Tangible Book Value Per Share	1.76	2.63	0.29	0.46	0.04	0.05
Machinery	-	6.34	6.44	6.01	6.92	5.55

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q